Abstract
The aim of the study was to examine the electrophysiological characteristics of human atrial specimens collected during heart surgery and to investigate the effects of the class I antiarrhythmic agent flecainide on their electrical activity. Atrial specimens were studied using standard microelectrode techniques, with and without superfused flecainide (5 x 10(-7) M) or the transient outward current inhibitor 4-aminopyridine (0.5 mM). Atrial fragments 0.5-1.0 cm2 were obtained at operation from 34 patients, mean age 30 years. There was no history of previous atrial arrhythmia in any patient and drug therapy was stopped 24 h before surgery. Two types of transmembrane action potential were identified: (1) triangular shaped potentials (group A, classically found in animal models); (2) potentials with a large plateau preceded by a notch (group B). The effect of flecainide was compared on the the two types of action potential. In both, flecainide lessened the depolarisation rate. In group B, but not in group A, it increased the action potential duration at 50% and 90% repolarisation (APD50, APD90) and the effective refractory period. The notch in group B action potentials is generated by transient outward currents (Ito). Inhibition of...Continue Reading
Citations
Mar 1, 1994·Clinical Cardiology·D Katritsis, A J Camm
May 1, 1995·Journal of Clinical Pharmacology·D BabutyP Peraudeau
Nov 1, 1992·Basic Research in Cardiology·S HatemE Deroubaix
Jun 1, 1996·International Journal of Cardiology·A A DawoduP E Puddu
May 1, 1992·Journal of the American College of Cardiology·G O'HaraS Nattel
Feb 20, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Ross J Hunter, Richard J Schilling
Dec 9, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Etienne AliotJuan Tamargo
May 1, 1995·Clinical and Experimental Pharmacology & Physiology·L L LuJ Morikawa
Jul 22, 2014·Cardiology in the Young·Rohit S LoombaTodd M Gudausky
Jan 12, 2001·Japanese Circulation Journal·H WatanabeK Kanmatuse
Feb 1, 1993·Circulation·S C Krishnan, C Antzelevitch
Oct 1, 1993·Circulation·J R WindleG J Rozanski
Jul 1, 1990·Circulation·Z G WangS Nattel
Aug 1, 1993·Circulation Research·Z WangS Nattel
Jan 24, 1998·Circulation Research·A NygrenW R Giles
Jul 15, 2017·Scientific Reports·Zachary LaksmanPeter H Backx
Aug 28, 2020·Frontiers in Physiology·Henggui ZhangWeijian Shen
Aug 5, 1998·The American Journal of Physiology·M CourtemancheS Nattel
Sep 12, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Björn C KnollmannMichael R Franz
Nov 10, 2020·Journal of Cardiovascular Pharmacology·Alexander Burashnikov
Jul 3, 2021·Cells·Daniel GratzThomas J Hund